Evidence map›Paper›PMID 33975417›Full record

ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2021

Chronic Obstructive Pulmonary Disease Outcomes at Veterans Affairs Versus Non-Veterans Affairs Hospitals.

Stephanie L LaBedz, Jerry A Krishnan, Yu-Che Chung, Peter K Lindenauer, Laura J Spece, Laura C Feemster, Ellen M Stein, Russell G Buhr, Sanjib Basu, Valentin Prieto-Centurion

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chronic obstructive pulmonary diseases (Miami, Fla.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Nasal Cannula Dislodgement During Sleep in Veterans Receiving Long-term Oxygen Therapy for Hypoxemic Chronic Respiratory Failure.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stephanie L LaBedzBreathe Chicago Center, Division of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois at Chicago, Chicago, Illinois, United States.
Jerry A KrishnanBreathe Chicago Center, Division of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois at Chicago, Chicago, Illinois, United States.
Yu-Che ChungBreathe Chicago Center, Division of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois at Chicago, Chicago, Illinois, United States.
Peter K LindenauerDepartment of Medicine, Institute for Healthcare Delivery and Population Science, University of Massachusetts Medical School - Baystate, Springfield, Massachusetts, United States.
Laura J SpeceHealth Services Research and Development, VA Puget Sound, Seattle, Washington, United States.
Laura C FeemsterHealth Services Research and Development, VA Puget Sound, Seattle, Washington, United States.
Ellen M SteinBreathe Chicago Center, Division of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois at Chicago, Chicago, Illinois, United States.
Russell G BuhrDivision of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, United States.
Sanjib BasuDivision of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, Illinois, United States.
Valentin Prieto-CenturionBreathe Chicago Center, Division of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois at Chicago, Chicago, Illinois, United States.

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
The Effect of Nanoparticle Encapsulated Resveratrol on Treatment of PeriodontitisKL2TR001882 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Elizabeta Nemeth · 2016 to 2026
$13.1M
University of Washington Implementation Science Training Program (UW-ISTP)K12K12HL137940 · NHLBI · UNIVERSITY OF WASHINGTON · PI AU, DAVID H, CURTIS, J RANDALL · 2017 to 2021
$2.9M
Postdoctoral Training Program in Pulmonary and Critical Care Translational ResearchT32HL144909 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDEK, STEVEN M, FINN, PATRICIA W · 2019 to 2023
$1.3M
Promoting Activity After COPD Exacerbations (PACE)K23HL130524 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PRIETO-CENTURION, VALENTIN · 2016 to 2019
$827k
Research and Mentoring in Comparative Effectiveness and Implementation ScienceK24HL132008 · NHLBI · BAYSTATE MEDICAL CENTER, INC. · PI LINDENAUER, PETER KYLE · 2016 to 2020
$574k
NCATS NIH HHS KL2 TR001882NCATS NIH HHS UL1 TR001881NHLBI NIH HHS K12 HL137940NHLBI NIH HHS K23 HL130524NHLBI NIH HHS K24 HL132008NHLBI NIH HHS T32 HL144909NIH HHS K12HL137940 (LJS)NIH HHS K23HL130524 (VPC)NIH HHS K24HL132008 (PKL)NIH HHS T32HL144909 (SLL)NIH HHS UL1TR001881 (RGB)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

copdmortalityreadmissionveterans

Identifiers

PMID33975417
PMCPMC8428592

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.